Moses Rodriguez Selected Research

Demyelinating Diseases (Demyelinating Disease)

1/2018	A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?
1/2018	Demyelination with preferential MAG loss: A complex message from MS paraffin blocks.
1/2016	AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
3/2015	Multiple sclerosis: the role of melatonin and N-acetylserotonin.
11/2014	Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.
9/2014	Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.
1/2014	Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
9/2013	Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.
9/2012	Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.
9/2012	Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moses Rodriguez Research Topics

Disease

67	Multiple Sclerosis 04/2022 - 01/2002
49	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 01/2002
21	Infections 10/2018 - 08/2002
13	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 11/2002
8	Virus Diseases (Viral Diseases) 10/2018 - 09/2003
8	Inflammation (Inflammations) 01/2016 - 03/2002
7	Neoplasms (Cancer) 01/2022 - 08/2002
4	Central Nervous System Diseases (CNS Diseases) 01/2019 - 12/2009
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 03/2002
4	Disease Progression 01/2018 - 09/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2016 - 04/2014
3	Fatigue 08/2016 - 07/2006
3	Spinal Cord Injuries (Spinal Cord Injury) 08/2016 - 10/2009
3	Stroke (Strokes) 08/2016 - 02/2004
2	Epstein-Barr Virus Infections 01/2022 - 10/2018
2	Genetic Risk Score 01/2020 - 04/2017
2	Relapsing-Remitting Multiple Sclerosis 12/2016 - 03/2016
2	Nervous System Diseases (Neurological Disorders) 08/2016 - 11/2015
2	Pain (Aches) 01/2016 - 03/2015
2	Neurocognitive Disorders (Clerambault Syndrome) 01/2016 - 12/2015
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2015 - 12/2009
2	Encephalomyelitis (Myeloencephalitis) 01/2012 - 04/2008
2	Chronic Progressive Multiple Sclerosis 12/2009 - 06/2008
2	Encephalitis (Encephalitis, Rasmussen) 01/2009 - 08/2002
2	Central Nervous System Infections (Central Nervous System Infection) 11/2003 - 01/2003
1	Residual Neoplasm 01/2022
1	Glioma (Gliomas) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Overweight 01/2022
1	Bites and Stings (Sting) 01/2020
1	Progressive Multifocal Leukoencephalopathy 01/2020
1	Chronobiology Disorders (Circadian Rhythm Disorder) 11/2019
1	Dysbiosis 11/2019
1	Atherosclerosis 01/2019
1	Herpes Simplex 10/2018

Drug/Important Bio-Agent (IBA)

15	AntibodiesIBA 11/2015 - 03/2002
13	Immunoglobulin M (IgM)IBA 01/2019 - 10/2003
13	Peptides (Polypeptides)IBA 11/2014 - 08/2002
11	Monoclonal AntibodiesIBA 01/2016 - 03/2002
8	AntigensIBA 09/2015 - 08/2002
8	Proteins (Proteins, Gene)FDA Link 02/2015 - 01/2002
6	Antiviral Agents (Antivirals)IBA 01/2020 - 09/2003
6	Capsid Proteins (Capsid Protein)IBA 01/2014 - 08/2002
5	AutoantibodiesIBA 01/2019 - 02/2004
5	EpitopesIBA 01/2017 - 06/2005
5	HLA-DR Antigens (HLA-DR)IBA 04/2009 - 12/2005
4	Immunoglobulins (Immunoglobulin)IBA 04/2022 - 03/2002
4	MelatoninIBA 11/2019 - 03/2015
4	CytokinesIBA 01/2016 - 01/2002
4	Tryptophan (L-Tryptophan)FDA Link 01/2016 - 03/2015
4	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2012 - 03/2002
3	Nucleotide AptamersIBA 01/2019 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 04/2015 - 01/2011
3	Histocompatibility Antigens Class IIIBA 11/2014 - 04/2007
3	Kallikreins (Kallikrein)IBA 09/2014 - 06/2008
3	PerforinIBA 09/2009 - 07/2004
2	Vitamin D FDA LinkGeneric 01/2020 - 04/2017
2	LipidsIBA 01/2020 - 12/2015
2	Natalizumab (Tysabri)FDA Link 01/2020 - 02/2011
2	A-Form DNA (A-DNA)IBA 01/2019 - 01/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 10/2018 - 12/2005
2	Immunoglobulin G (IgG)IBA 01/2017 - 07/2011
2	GangliosidesIBA 01/2017 - 08/2015
2	SaltsIBA 12/2016 - 03/2016
2	Neuroprotective AgentsIBA 08/2016 - 01/2003
2	Interleukin-17 (Interleukin 17)IBA 01/2016 - 11/2014
2	KynurenineIBA 01/2016 - 12/2015
2	polysialic acidIBA 09/2015 - 08/2015
2	Neutralizing AntibodiesIBA 09/2012 - 04/2008
2	N-acetylaspartate (N-acetyl aspartate)IBA 09/2012 - 10/2009
2	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 06/2012 - 04/2005
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2012 - 02/2004
2	SteroidsIBA 07/2011 - 01/2011
2	CuprizoneIBA 02/2011 - 04/2007
2	Glatiramer Acetate (Copaxone)FDA Link 02/2011 - 08/2002
2	InterferonsIBA 01/2011 - 02/2004
2	Myelin-Oligodendrocyte GlycoproteinIBA 12/2005 - 04/2003
2	ChemokinesIBA 05/2005 - 01/2003
2	Interferon-gamma (Interferon, gamma)IBA 11/2003 - 08/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2002 - 11/2002
1	SmokeIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	16S Ribosomal RNAIBA 01/2021
1	hydroxide ionIBA 01/2020
1	25-hydroxyvitamin DIBA 01/2020
1	CeramidesIBA 11/2019
1	Butyrates (Butyrate)IBA 11/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2019
1	Volatile Fatty AcidsIBA 11/2019
1	OrexinsIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2018
1	ParaffinIBA 01/2018
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2018

Therapy/Procedure

28	Therapeutics 01/2022 - 03/2002
3	Plasma Exchange 07/2011 - 08/2005
1	Intravenous Infusions 04/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Injections 01/2020
1	Pacifiers 05/2018